The invention provides methods and compositions for the treatment of cancersassociated with overexpression of a BCL2 gene and/or gene product in asubject, andmethods and compositions for the improvement of anti-cancer therapy, such aschemotherapy and radiation therapy. The invention also encompasses methods fordetermining the efficacy of a cancer therapy in a subject and methods forinducingapoptosis of a cell.